Search Statements

Whether or not countries coordinate procurement, they must publish the specific technical and governance requirements they impose on AI vendors.

Procurement guarantees should cover only narrow, demonstrable safety outcomes—not broad industrial policy goals like domestic AI champions.

Public procurement should include diverse stakeholder input to ensure comprehensive AI governance.

Any government using AI in public services should be transparent about what guarantees it requires vendors to meet before purchase.

AI governance frameworks must not hinder innovation in public procurement processes.

Governments should actively collaborate with international partners on AI procurement standards.

AI procurement policies must balance regulatory oversight with the need for rapid technological advancement.

Increased regulation of AI procurement will stifle competition and innovation.

Public procurement processes for AI must be transparent to build public trust and accountability.

Public procurement of AI technologies must ensure equitable access for underserved communities.

Policymakers should test whether Medicare Advantage payment models and regulatory frameworks can be adapted to improve Medicaid managed care performance.

Private insurers operating Medicaid plans prioritize profit over care coordination for low-income patients, unlike non-profit alternatives.

State Medicaid programs should be allowed to shift more enrollees into private managed plans if those plans meet measurable quality and access standards.

The debate over Medicaid and private plans should focus on improving patient care and outcomes.

Low-income Medicaid beneficiaries lack the health literacy and market knowledge to make informed choices between competing private plans.

Private Medicare Advantage plans deliver better outcomes than traditional Medicare because competition forces them to innovate and control costs.

Medicaid serves as a crucial safety net for low-income individuals, which private plans cannot replicate.

Federal funding formulas should tie Medicaid reimbursement to the same quality benchmarks applied to Medicare Advantage, not lower thresholds.

Medicaid should prioritize preventive care to improve health outcomes and reduce costs.

Medicaid should be restructured to incorporate more private sector competition.